Literature DB >> 9225895

Diagnosis of Alzheimer's disease in a community hospital-based brain bank program.

G S Pearl1.   

Abstract

Several studies in recent years have addressed the accuracy of the clinical diagnosis of Alzheimer's disease (AD). However, most large studies have been done in university centers specializing in dementia. The purpose of this study was to assess the diagnostic accuracy of dementia in a community-based brain bank program, using data from the Central Florida component of the State of Florida's Brain Bank Program. Since 1987, 261 cases of dementia have been assessed at antopsy, and the clinical and pathologic diagnoses were compared. Of 234 patients with a clinical diagnosis of AD, 181 (77%) had a pathologic diagnosis of AD, with or without other contributing disorders. Of 27 patients with a clinical diagnosis of non-AD dementia, 14 (52%) had a pathologic diagnosis of AD, with or without other contributing diagnoses. These findings are similar to those previously reported and emphasize the importance of autopsy for the accurate diagnosis of dementia for genetic counseling, assessment of diagnostic techniques or drug therapy, and epidemiologic studies.

Entities:  

Mesh:

Year:  1997        PMID: 9225895     DOI: 10.1097/00007611-199707000-00013

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  11 in total

1.  In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).

Authors:  Dean F Wong; Paul B Rosenberg; Yun Zhou; Anil Kumar; Vanessa Raymont; Hayden T Ravert; Robert F Dannals; Ayon Nandi; James R Brasić; Weiguo Ye; John Hilton; Constantine Lyketsos; Hank F Kung; Abhinay D Joshi; Daniel M Skovronsky; Michael J Pontecorvo
Journal:  J Nucl Med       Date:  2010-06       Impact factor: 10.057

Review 2.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

Review 3.  Diffuse Lewy body disease: clinical, pathological, and neuropsychological review.

Authors:  C A Luis; W Mittenberg; C S Gass; R Duara
Journal:  Neuropsychol Rev       Date:  1999-09       Impact factor: 7.444

4.  Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography.

Authors:  Kuan-Yi Wu; Ing-Tsung Hsiao; Cheng-Sheng Chen; Chia-Hsiang Chen; Chia-Ju Hsieh; Yau-Yau Wai; Chee-Jen Chang; Hsiao-Jung Tseng; Tzue-Chen Yen; Chia-Yih Liu; Kun-Ju Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04       Impact factor: 9.236

5.  Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.

Authors:  Keith A Johnson; Reisa A Sperling; Christopher M Gidicsin; Jeremy S Carmasin; Jacqueline E Maye; Ralph E Coleman; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Adam S Fleisher; P Murali Doraiswamy; Alan P Carpenter; Christopher M Clark; Abhinay D Joshi; Ming Lu; Michel Grundman; Mark A Mintun; Michel J Pontecorvo; Daniel M Skovronsky
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

6.  Amyloid deposition, hypometabolism, and longitudinal cognitive decline.

Authors:  Susan M Landau; Mark A Mintun; Abhinay D Joshi; Robert A Koeppe; Ronald C Petersen; Paul S Aisen; Michael W Weiner; William J Jagust
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

7.  Low sensitivity in clinical diagnoses of dementia with Lewy bodies.

Authors:  Peter T Nelson; Gregory A Jicha; Richard J Kryscio; Erin L Abner; Frederick A Schmitt; Gregory Cooper; Li O Xu; Charles D Smith; William R Markesbery
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

8.  Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.

Authors:  Kun-Ju Lin; Ing-Tsung Hsiao; Jung-Lung Hsu; Chin-Chang Huang; Kuo-Lun Huang; Chia-Ju Hsieh; Shiaw-Pyng Wey; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-22       Impact factor: 9.236

9.  Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians.

Authors:  W Mok; T W Chow; L Zheng; W J Mack; C Miller
Journal:  Am J Alzheimers Dis Other Demen       Date:  2004 May-Jun       Impact factor: 2.035

10.  Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.

Authors:  Milos D Ikonomovic; William E Klunk; Eric E Abrahamson; Chester A Mathis; Julie C Price; Nicholas D Tsopelas; Brian J Lopresti; Scott Ziolko; Wenzhu Bi; William R Paljug; Manik L Debnath; Caroline E Hope; Barbara A Isanski; Ronald L Hamilton; Steven T DeKosky
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.